Argenx
ARGX
#415
Rank
$56.09 B
Marketcap
$900.76
Share price
-0.05%
Change (1 day)
47.42%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total assets

Total assets on the balance sheet as of June 2025 : $7.17 Billion USD

According to Argenx 's latest financial reports the company's total assets are $7.17 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Argenx - Total assets on balance sheet (from 2021 to 2020)

Total assets by year

Year Total assets Change
2024-12-31$6.20 B36.55%
2023-12-31$4.54 B44.93%
2022-12-31$3.13 B9.96%
2021-12-31$2.85 B1.66%
2020-12-31$2.80 B55.43%
2019-12-31$1.80 B138.29%
2018-12-31$0.75 B41.78%
2017-12-31$0.53 B356.3%
2016-12-31$0.11 B112.96%
2015-12-31$54.94 M-36.5%
2014-12-31$86.53 M81.41%
2013-12-31$47.69 M57.27%
2012-12-31$30.33 M-26.88%
2011-12-31$41.48 M154.34%
2010-12-31$16.3 M